PBF, a Proto-oncogene in Esophageal Carcinoma.Emerging evidence shows that the pituitary tumour-transforming gene (PTTG)-binding factor (PBF) functions as a proto-oncogene in some tumors.  However, the precise functions of PBF in tumorigenesis and its action mechanisms remain largely unknown.  Here for the first time we demonstrated that PBF was associated with a tumor-related cell phenotype in esophageal carcinoma (ESCA) and identified the involved signaling pathways.  PBF was up-regulated in ESCA tissues (Data from GEPIA) and cells.  Then we down-regulated PBF in ESCA cell lines, Eca-109 and TE-1, by using RNAi technology.  Cell function analysis suggested that down-regulation of PBF could inhibit tumor-related cell phenotypes, including proliferation, motility, apoptosis and cell cycle, in Eca-109 and TE-1 cells.  Mechanism investigation suggested that apoptosis induced by PBF knockdown may be mediated by the activation of the mitochondrial apoptosis pathway and cell cycle arrest.  AKT/mTOR and Wnt3a/β-catenin, key pathways in regulating tumor proliferation and metastasis, were found to be inactivated by the down-regulation of PBF in ESCA cells.  In conclusion, our study demonstrates that PBF functions as a proto-oncogene in ESCA in vitro, which may be mediated through AKT/mTOR and Wnt3a/β-catenin pathways.
PBF
PBF was up-regulated in ESCA tissues (Data from GEPIA) and cells. 
GEPIA